1. Home
  2. BCDA vs MMA Comparison

BCDA vs MMA Comparison

Compare BCDA & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$1.20

Market Cap

12.7M

Sector

Health Care

ML Signal

HOLD

MMA

Alta Global Group Limited

HOLD

Current Price

$0.46

Market Cap

10.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
MMA
Founded
N/A
2013
Country
United States
Australia
Employees
17
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7M
10.5M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
BCDA
MMA
Price
$1.20
$0.46
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
69.1K
501.5K
Earning Date
03-24-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.35
52 Week High
$3.20
$2.88

Technical Indicators

Market Signals
Indicator
BCDA
MMA
Relative Strength Index (RSI) 42.07 44.87
Support Level $1.10 $0.35
Resistance Level $1.39 $0.71
Average True Range (ATR) 0.09 0.06
MACD -0.01 0.02
Stochastic Oscillator 17.21 77.14

Price Performance

Historical Comparison
BCDA
MMA

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About MMA Alta Global Group Limited

Mixed Martial Arts Group Ltd is a technology company operating in the martial arts and combat sports industry. The company operate four core business units: i) TrainAlta: A platform that transforms MMA fans into active participants through structured training programs like the Warrior Training Program, ii) BJJLink: A gym management platform designed for BJJ academies, offering tools for payment processing, marketing, student engagement, and content monetization, iii) Hype: A marketing platform helping gym owners, coaches, and athletes grow revenue from their audiences, iv) MixedMartialArts.com: The go-to resource for MMA news, fighter data, fight schedules, and the legendary Underground forum. Its majority of revenue is in the form of Program revenue, which consists of the license fees.

Share on Social Networks: